ARTICLE | Clinical News
Phase II results for Altropane
March 12, 2001 8:00 AM UTC
Boston Life Sciences (BLSI) said in a U.S. Phase II trial of its Altropane radio-imaging agent in combination with SPECT imaging to detect attention hyperactivity deficit disorder (ADHD) in 40 adults,...